D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CERE holding history
Cerevel Therapeutics Holdings, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERE overviewAll 13F holders of CEREFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −44,442−100.0% | Sold out | Holders |
| Q2 2024 | 44,442 | $1.82M | <0.1% | −377,573−89.5% | Reduced | Holders |
| Q1 2024 | 422,015 | $17.8M | <0.1% | +422,015 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −8,700−100.0% | Sold out | Holders |
| Q4 2021 | 8,700 | $282.0K | <0.1% | −14,881−63.1% | Reduced | Holders |
| Q3 2021 | 23,581 | $696.0K | <0.1% | +23,581 | New | Holders |